Article info
PDFNeurological rarities
Myelopathy associated with intrathecal methotrexate
- Correspondence to Pedro Gustavo Barros Rodrigues, Division of Neurology, Department of Clinical Medicine, Universidade Federal do Ceará, Fortaleza, Ceará 60430-160, Brazil; gustavo.rodrigues675{at}hotmail.com
Citation
Myelopathy associated with intrathecal methotrexate
Publication history
- Accepted October 3, 2021
- First published October 29, 2021.
Online issue publication
March 18, 2022
Article Versions
- Previous version (18 March 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Myelopathy but normal MRI: where next?
- Hypothesis on the pathogenesis of vacuolar myelopathy, dementia, and peripheral neuropathy in AIDS
- Progressive unsteadiness in a 68-year-old man with longstanding abdominal pain and altered bowel habit
- Spinal cord involvement in adult-onset metabolic and genetic diseases
- Early treatment causes clinicoradiological reversal of myelopathy due to vitamin B12 deficiency
- Subacute combined degeneration: a case of pernicious anaemia without haematological manifestations
- Nitrous oxide-induced subacute combined degeneration of the cord: diagnosis and treatment
- Functional vitamin B12 deficiency
- A practical approach to the diagnosis of spinal cord lesions
- A man with tingling fingers